186 related articles for article (PubMed ID: 11443849)
1. Multiple endocrine neoplasia type 2: clinical aspects.
Gimm O
Front Horm Res; 2001; 28():103-30. PubMed ID: 11443849
[No Abstract] [Full Text] [Related]
2. [Multiple endocrine neoplasia type IIa (MEN2A)].
Hashizume K; Suzuki S; Shigematsu S; Takeda T
Nihon Rinsho; 2006 Sep; Suppl 3():337-42. PubMed ID: 17022559
[No Abstract] [Full Text] [Related]
3. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
[TBL] [Abstract][Full Text] [Related]
4. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
[TBL] [Abstract][Full Text] [Related]
5. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
[TBL] [Abstract][Full Text] [Related]
6. [Polyadenomatoses: type 2 multiple endocrine neoplasms].
Conte-Devolx B; Niccoli-Sire P;
Presse Med; 2002 Aug; 31(26):1224-30. PubMed ID: 12212516
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia type 2.
Lodish M
Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
[TBL] [Abstract][Full Text] [Related]
8. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
Nilsson O; Tisell LE; Jansson S; Ahlman H; Gimm O; Eng C
JAMA; 1999 May; 281(17):1587-8. PubMed ID: 10235148
[No Abstract] [Full Text] [Related]
9. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
Moers AM; Landsvater RM; Schaap C; Jansen-Schillhorn van Veen JM; de Valk IA; Blijham GH; Höppener JW; Vroom TM; van Amstel HK; Lips CJ
Am J Med; 1996 Dec; 101(6):635-41. PubMed ID: 9003111
[TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia type 2 (MEN 2).
Frank-Raue K; Raue F
Eur J Cancer; 2009 Sep; 45 Suppl 1():267-73. PubMed ID: 19775624
[No Abstract] [Full Text] [Related]
11. Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan.
Egawa S; Futami H; Takasaki K; Iihara M; Okamoto T; Kanbe M; Ohi T; Saio Y; Miyauchi A; Takiyama Y; Koga M; Miyanaga K; Inoue K; Mitsuyama S; Nomura Y; Takei H; Mugiya S; Ishida O; Zeze F; Shakutsui S; Inoue H; Oya H; Yoshimura A; Ishizuka S; Yamaguchi K
Jpn J Clin Oncol; 1998 Oct; 28(10):590-6. PubMed ID: 9839497
[TBL] [Abstract][Full Text] [Related]
12. Composite phaeochromocytoma-ganglioneuroblastoma in a patient with multiple endocrine neoplasia type IIA.
Matias-Guiu X; Garrastazu MT
Histopathology; 1998 Mar; 32(3):281-2. PubMed ID: 9568520
[No Abstract] [Full Text] [Related]
13. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
14. [Consequences of clinical genetic analysis of RET proto-oncogene].
Włoch J; Wygoda Z; Wiench M; Gubała E; Kula D; Oczko M; Lange D; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():406-14. PubMed ID: 12182057
[TBL] [Abstract][Full Text] [Related]
15. Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report.
Yamashita T; Lihara M; Okamoto J; Kanbe M; Ito Y; Kawakami M; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Feb; 27(1):42-5. PubMed ID: 9070340
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
Eng C; Foster KA; Healey CS; Houghton C; Gayther SA; Mulligan LM; Ponder BA
Br J Cancer; 1996 Aug; 74(3):339-41. PubMed ID: 8695346
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study.
Nguyen L; Niccoli-Sire P; Caron P; Bastie D; Maes B; Chabrier G; Chabre O; Rohmer V; Lecomte P; Henry JF; Conte-Devolx B;
Eur J Endocrinol; 2001 Jan; 144(1):37-44. PubMed ID: 11174835
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 2: recent progress in diagnosis and management.
Heshmati HM; Hofbauer LC
Eur J Endocrinol; 1997 Dec; 137(6):572-8. PubMed ID: 9437218
[No Abstract] [Full Text] [Related]
19. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
20. [Multiple endocrine neoplasia type 2].
Maia AL; Gross JL; Puñales MK
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):725-34. PubMed ID: 16444355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
